Literature DB >> 3544523

The use of plasma substitutes with special attention to their side effects.

K F Messmer.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3544523     DOI： 10.1007/BF01658463

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  34 in total

1.  Dextran and the prevention of postoperative thromboembolic complications.

Authors:  U F Gruber
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

Review 2.  Colloids for blood volume support.

Authors:  U F Gruber; K Messmer
Journal:  Prog Surg       Date:  1977

3.  Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject.

Authors:  W Lorenz; A Doenicke; B Schöning; C Ohmann; B Grote; E Neugebauer
Journal:  Klin Wochenschr       Date:  1982-09-01

4.  Incidence and classification of adverse reactions to plasma substitutes.

Authors:  J Ring; H Laubenthal; K Messmer
Journal:  Klin Wochenschr       Date:  1982-09-01

5.  Systemic anaphylaxis secondary to the use of 5 per cent plasma protein fractions.

Authors:  R D McMillin; T R Hood; W O Griffen
Journal:  Am J Surg       Date:  1978-05       Impact factor: 2.565

6.  The dextrans--clinical data.

Authors:  L Thorén
Journal:  Dev Biol Stand       Date:  1980

7.  Effect of dextran on factor VIII (antihemophilic factor) and platelet function.

Authors:  M Aberg; U Hedner; S E Bergentz
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

8.  Adverse reactions to human plasma proteins.

Authors:  J V Wells; M A King
Journal:  Anaesth Intensive Care       Date:  1980-05       Impact factor: 1.669

9.  [Haemaccel 35: adverse reactions in a multicentric, prospective study].

Authors:  K H Weis
Journal:  Anaesthesist       Date:  1983-10       Impact factor: 1.041

10.  Prophylaxis of anaphylactoid reactions to a polypeptidal plasma substitute by H1- plus H2-receptor antagonists: synopsis of three randomized controlled trials.

Authors:  B Schöning; W Lorenz; A Doenicke
Journal:  Klin Wochenschr       Date:  1982-09-01
View more
  5 in total

1.  In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.

Authors:  Alexander A Hanke; Stephanie Maschler; Herbert Schöchl; Felix Flöricke; Klaus Görlinger; Klaus Zanger; Peter Kienbaum
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-02-10       Impact factor: 2.953

2.  Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept.

Authors:  E Klar; T Foitzik; H Buhr; K Messmer; C Herfarth
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

Review 3.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

4.  Safety and tolerability of volplex((r)) in elective surgery.

Authors:  Robert J Sneyd; Bernard C Dean; Colum Dwyer
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 5.  Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.

Authors:  M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz
Journal:  Intensive Care Med       Date:  2017-06-02       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.